Fundamental Valuation Report Anaplan(PLAN:NYS) Technology:Software – Infrastructure This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$59.65 (USD) 04/30/2021 Weighted Valuation$55.29 (USD) Overall RatingOvervalued by 7.3% Valuation Models Comparables: $53.67 (USD) (in …

Anaplan (PLAN:NYS) Fundamental Valuation Report Read more »

Read More

Fundamental Valuation Report Kadant(KAI:NYS) Industrials:Specialty Industrial Machinery This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$178.03 (USD) 04/30/2021 Weighted Valuation$166.95 (USD) Overall RatingOvervalued by 6.2% Valuation Models Comparables: $167.25 (USD) Comparables: $133.60 …

Kadant (KAI:NYS) Fundamental Valuation Report Read more »

Read More

Fundamental Valuation Report Goldman Sachs BDC(GSBD:NYS) Financial Services:Credit Services This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$19.58 (USD) 04/30/2021 Weighted Valuation$18.51 (USD) Overall RatingOvervalued by 5.4% Valuation Models Adjusted …

Goldman Sachs BDC (GSBD:NYS) Fundamental Valuation Report Read more »

Read More

Fundamental Valuation Report Intercept Pharmaceuticals(ICPT:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$19.78 (USD) 04/30/2021 Weighted Valuation$10.32 (USD) Overall RatingOvervalued by 47.8% Valuation Models Comparables: $10.32 (USD) Valuation Methods …

Intercept Pharmaceuticals (ICPT:NAS) Fundamental Valuation Report Read more »

Read More

Fundamental Valuation Report Guardant Health(GH:NAS) Healthcare:Diagnostics & Research This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$160.70 (USD) 04/29/2021 Weighted Valuation$138.78 (USD) Overall RatingOvervalued by 13.6% Valuation Models Comparables: $153.46 (USD) …

Guardant Health (GH:NAS) Fundamental Valuation Report Read more »

Read More

Fundamental Valuation Report GenMark Diagnostics(GNMK.DL:NAS) Healthcare:Medical Devices This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$24.04 (USD) 04/22/2021 Weighted Valuation$21.70 (USD) Overall RatingOvervalued by 9.7% Valuation Models Comparables: $18.19 (USD) Multiples: $18.56 …

GenMark Diagnostics (GNMK.DL:NAS) Fundamental Valuation Report Read more »

Read More

Fundamental Valuation Report Bed Bath & Beyond(BBBY:NAS) Consumer Cyclical:Specialty Retail This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$26.52 (USD) 04/23/2021 Weighted Valuation$20.50 (USD) Overall RatingOvervalued by 22.7% Valuation Models …

Bed Bath & Beyond (BBBY:NAS) Fundamental Valuation Report Read more »

Read More

Finance trade manager analysing stock market indicators for best investment strategy, financial data and charts with business buildings in background

Fundamental Valuation Report Curtiss-Wright(CW:NYS) Industrials:Specialty Industrial Machinery This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$125.10 (USD) 04/22/2021 Weighted Valuation$117.61 (USD) Overall RatingOvervalued by 6.0% Valuation Models Adjusted Book Value: $126.73 …

Curtiss-Wright (CW:NYS) Fundamental Valuation Report Read more »

Read More

Fundamental Valuation Report California Water Service(CWT:NYS) Utilities:Utilities – Regulated Water This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$61.35 (USD) 04/22/2021 Weighted Valuation$52.37 (USD) Overall RatingOvervalued by 14.6% Valuation Models …

California Water Service (CWT:NYS) Fundamental Valuation Report Read more »

Read More

Fundamental Valuation Report Cyclerion Therapeutics(CYCN:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$2.78 (USD) 04/22/2021 Weighted Valuation$2.55 (USD) Overall RatingOvervalued by 8.1% Valuation Models Adjusted Book Value: $2.68 (USD) …

Cyclerion Therapeutics (CYCN:NAS) Fundamental Valuation Report Read more »

Read More